COVID-19 and immune checkpoint inhibitors: initial considerations

COVID-19 infections are characterized by inflammation of the lungs and other organs that ranges from mild and asymptomatic to fulminant and fatal. Patients who are immunocompromised and those with cardiopulmonary comorbidities appear to be particularly afflicted by this illness. During pandemic cond...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Immunother Cancer
Hauptverfasser: Sullivan, Ryan J, Johnson, Douglas B, Rini, Brian I, Neilan, Tomas G, Lovly, Christine M, Moslehi, Javid J, Reynolds, Kerry L
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group 2020
Schlagworte:
Commentary
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7246104/
https://ncbi.nlm.nih.gov/pubmed/32434790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000933
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge